Growth Hormone

Tesamorelin vs Sermorelin: FDA-Approved vs Classic GHRH Analogue

Verdict Summary

Tesamorelin has FDA approval for HIV-associated lipodystrophy and strong clinical data for visceral fat reduction. Sermorelin is more commonly used off-label for anti-aging and GH optimization with a longer track record in that context.

Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →

At a Glance

DimensionTesamorelinSermorelin
FDA StatusApproved (HIV lipodystrophy)Approved (pediatric GH deficiency)
Primary UseVisceral fat reductionGH optimization / anti-aging
Half-Life~30 minutes~10-20 minutes
Clinical DataStrong (visceral fat)Moderate (GH deficiency)

Tesamorelin Deep Dive

Tesamorelin is a stabilized GHRH analogue with FDA approval for reducing visceral adipose tissue in HIV patients. Its clinical data for visceral fat reduction is among the strongest of any peptide, making it relevant for metabolic health protocols.

Sermorelin Deep Dive

Sermorelin has been used off-label for adult GH optimization for decades. It produces physiological pulsatile GH release and is often considered the most natural GHRH analogue approach to GH support.

How to Choose

Choose Tesamorelin if…

  • Visceral fat reduction is a primary goal
  • You want the strongest clinical data for metabolic effects
  • You are working with a physician familiar with tesamorelin

Choose Sermorelin if…

  • General GH optimization is the goal
  • Physiological pulsatile GH release is preferred
  • Cost is a consideration

Still Unsure?

Get a personalized recommendation

Take the 5-minute PeptidePilot quiz. Our algorithm evaluates your goals, body, and lifestyle to recommend the right peptide for you — vendor-neutral.

Frequently Asked Questions

More Comparisons